An urgent review is needed to ensure that people in England can get weight loss officers such as Wegovy and Mountrao on NHS, as well as warnings from senior experts.
It comes a day after the Prime Minister said that this injection may strengthen the economy of Britain Obtaining obesity “return to work”.
More than 200 physicians and specialists have now written to the Minister of Health to say how to face NHS Obesity Treatment Services, an unprecedented request from patients who want these medications.
They warn that injections are only a part that should be a broader set of unparalleled care.
They say that the government should suit some basic issues in obesity services in NHS – a lack of chronic financing, the challenges of workforce and the unequal access to care.
The message is sent to Wes Streeting by Obesity Health Alliance (OHA), which represents health charities and medical royal colleges, has collected a report.
She says that some patients can wait for up to five years to obtain specialized support, and that some services are very typical because they have completely closed their waiting lists.
OHA wants to see a fair access to obesity treatments, including weight loss injections.
There were reports on a global shortage of stocks, and at the present time in the UK on NHS, injections can only be provided through specialized weight management services.
Some patients go private, but many others miss, oha.
According to OHA, about four million people in England are eligible to get Wegovy, but NHS expectations are estimated that by 2028, less than 50,000 people will receive treatment.
Catherine Jenner, OHA director, said that losing weight was effective, but this was not the full picture.
“Even if you are taking strikes that still need to get an additional care and support around it, you still need to exercise and get food advice as well, and this is not currently present.
“There is also anxiety about what is getting this medicine. We need to make sure to give priority to reaching based on the biggest clinical need and not on any other factors.”
She added that OHA has heard about people who have the right to reach treatment services due to their extra weight.
“They have to request a special treatment and do not get the care and support package they expect to obtain if you have any other kind,” she said.
“We need to review the current NHS services to determine cases of really best good practices and determine those challenges everywhere.”
the Next approval The report warns that NHS to use another injection, calls it, which is called by some as the King Kong for weight loss for the extent of its appearance in experiments, is expected to put more pressure on the system.
“The new weight loss drugs are a breakthrough in treatment, giving millions of people struggling to manage their weight, but they also offer weaknesses in our current obesity services,” said Alfie Slade, OHA’s Affairs, said:
“Without urgent government interference, we will fail to meet the needs of millions of patients, which leads to more health inequality.”
Despite the benefits, health experts also warn that wegovy and mounjaro, who simulate the hormone that makes people less hungry, are not a quick solution. Patients must exercise and see what they eat.
Users can put the weight again once the drug is stopped.
As with any medication, there can be side effects.
Doctors are concerned about the increasing numbers of patients who see them with complications from taking overwhelming weight loss medications without clinical supervision.
In many cases, people may not actually get what they think, which can be very dangerous.
OHA says public health measures to help prevent obesity problems in the first place, such as improving a country in the country and helping children get enough practice, OHa says.
NHS England said it is working with the government and industry to develop new types of services that mean that the treatments approved can be offered safely, effectively and at reasonable prices.
“It helps more people lose weight and reduce the risk of fatal conditions such as diabetes, heart attack and stroke,” said a spokesman for weight loss.
A spokesman for the Ministry of Health and Social Welfare said that obesity “costs more than 11 billion pounds annually, and it also puts a great burden on our economy.”
They said: “With obesity -related disease, which causes people to take more than days of disease, obesity drugs can be part of the solution.”
The spokesperson also said that the advertising restrictions of fast food and a prohibition on selling high caffeine energy drinks for children would help treat the “obesity crisis”.